SNNAQ (Sienna Biopharmaceuticals) ROCE %: -54.82% (As of Sep. 2019)


What is Sienna Biopharmaceuticals ROCE %?

Sienna Biopharmaceuticals SNNAQ -99.00% ROCE % is -54.82% as of Sep. 2019.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sienna Biopharmaceuticals's annualized ROCE % for the quarter that ended in Sep. 2019 was -54.82%.

Sienna Biopharmaceuticals  (OTCPK:SNNAQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sienna Biopharmaceuticals ROCE % Related Terms

Sienna Biopharmaceuticals ROCE % Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals ROCE % Chart

Sienna Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18
ROCE %
-234.14 -72.29 -53.64 -72.32

Sienna Biopharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.29 -88.22 -72.18 -34.45 -54.82

Sienna Biopharmaceuticals ROCE % Calculation

Sienna Biopharmaceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2018 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2018 )  (A: Dec. 2017 )(A: Dec. 2018 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2018 )  (A: Dec. 2017 )(A: Dec. 2018 )
=-76.498/( ( (136.847 - 8.241) + (107.306 - 24.349) )/ 2 )
=-76.498/( (128.606+82.957)/ 2 )
=-76.498/105.7815
=-72.32 %

Sienna Biopharmaceuticals's ROCE % of for the quarter that ended in Sep. 2019 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2019 )  (Q: Jun. 2019 )(Q: Sep. 2019 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2019 )  (Q: Jun. 2019 )(Q: Sep. 2019 )
=-35.364/( ( (107.625 - 20.813) + (43.492 - 1.292) )/ 2 )
=-35.364/( ( 86.812 + 42.2 )/ 2 )
=-35.364/64.506
=-54.82 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2019) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -54.82% mean?
Sienna Biopharmaceuticals (SNNAQ) has a ROCE % of -54.82% as of Sep. 2019.
Is Sienna Biopharmaceuticals' ROCE % too high?
Sienna Biopharmaceuticals' current ROCE % is -54.82%.
How does Sienna Biopharmaceuticals' ROCE % compare to GTHR and PPCB?
Sienna Biopharmaceuticals' ROCE % of -54.82% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Sienna Biopharmaceuticals's current ROCE % is -54.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current ROCE % of -54.82%. The current ROCE % is -54.82%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current ROCE % is -54.82% as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.